| Clifford Matushin Pc | |
|
201 S Lloyd St Ste 140 Aberdeen SD 57401-4519 | |
| (605) 229-2544 | |
| (605) 229-2115 |
| Full Name | Clifford Matushin Pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 201 S Lloyd St Ste 140, Aberdeen, South Dakota |
| Authorized Official Name and Position | Clifford Michael Matushin (PHYSICIAN) |
| Authorized Official Contact | 6052292544 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Clifford Matushin Pc 201 S Lloyd St Ste 140 Aberdeen SD 57401-4519 Ph: (605) 229-2544 | Clifford Matushin Pc 201 S Lloyd St Ste 140 Aberdeen SD 57401-4519 Ph: (605) 229-2544 |
| NPI Number | 1861602500 |
|---|---|
| Provider Enumeration Date | 05/23/2007 |
| Last Update Date | 10/03/2007 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861602500 | NPI | - | NPPES |
| 6002770 | Medicaid | SD | |
| 4997166 | Other | SD | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 3575 (South Dakota) | Primary |
News Archive
Two independent advisory panels to the Food and Drug Administration (FDA) on Friday recommended increasing the cautionary language on the product labels of bone-building drugs taken by more than five million women in the United States. They did not however mention the exact words of the safety warnings and did not recommend limiting use of the drugs to a proposed five years. About 11 percent of women 55 and older take the drugs to prevent bone fractures.
In recent years, an overwhelming body of clinical evidence has firmly established the HIV Undetectable = Untransmittable concept as scientifically sound, say officials from the National Institutes of Health.
Teva Pharmaceutical Industries Ltd. announced today that a jury returned a verdict in the U.S. District Court for the District of New Jersey finding that Nycomed's U.S. Patent No. 4,758,579 is not invalid. The Court has reserved decision on the issue of what, if any, effect to give to the jury's determinations in connection with the obviousness-type double patenting defenses, which Teva has argued is to be decided by the Court.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that a large number of data presentations sponsored by the companies on ELIQUIS (apixaban) and the treatment of atrial fibrillation will be presented at the American Heart Association 2012 Scientific Sessions, November 3-7, 2012, in Los Angeles, California.
› Verified 4 days ago
Avera Aberdeen Family Physicians Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 105 S State St Ste 113, Aberdeen, SD 57401 Phone: 605-225-0378 Fax: 605-225-7919 | |
Aberdeen Community Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 506 S Wilson St, Aberdeen, SD 57401 Phone: 605-725-3900 Fax: 605-725-3901 | |
Kathleen Van De Walle Do Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1314 N Main St, Aberdeen, SD 57401 Phone: 605-229-3682 | |
Aberdeen Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 201 S Lloyd St, Suite W270, Aberdeen, SD 57401 Phone: 605-225-4070 Fax: 605-725-2416 | |
Tiny Knight Safety And Assurance Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 202 S Main St Ste 530, Aberdeen, SD 57401 Phone: 605-216-9777 | |
Sanford Aberdeen Cardiology Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3015 3rd Ave Se, Aberdeen, SD 57401 Phone: 605-226-5500 Fax: 605-226-5601 | |
Internal Medicine Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 201 S Lloyd St, Suite E101, Aberdeen, SD 57401 Phone: 605-225-8800 Fax: 605-225-1302 |